Healixa Inc.
EMOR · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 6,688.5% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 35.2% | -275.3% | – | -83.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7 | $1 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $7 | $1 | $3 | $3 |
| Operating Income | -$6 | -$1 | -$3 | -$3 |
| % Margin | -1,060.9% | -6,292.1% | – | -5,170.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$12 |
| Pre-Tax Income | -$7 | -$1 | -$3 | -$15 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7 | -$1 | -$3 | -$15 |
| % Margin | -1,123.8% | -7,316.1% | – | -25,329.4% |
| EPS | -0.009 | -0.001 | -0.004 | -0.019 |
| % Growth | -987.5% | 77.1% | 81.2% | – |
| EPS Diluted | -0.009 | -0.001 | -0.004 | -0.019 |
| Weighted Avg Shares Out | 773 | 778 | 817 | 810 |
| Weighted Avg Shares Out Dil | 773 | 778 | 817 | 810 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$1 | -$3 | -$15 |
| % Margin | -1,055.4% | -5,916.8% | – | -25,166.4% |